ArticleACS catalysis2026
Generative Artificial Intelligence-Empowered Virtual Evolution of Enzyme with the VERnet Model.
Article in ACS catalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models (LLMs) have demonstrated their limitations in addressing the design of active proteins that rely on intricate intramolecular interactions, particularly in the engineering of biocatalysts. Conducting real-world studies from targeted laboratory assays has become the de facto standard for artificial intelligence (AI) research in complex biological tasks. In this study, we present a standardized strategy using function-targeted models to decode the subtle effect of sequence variations on the function. Unlike affinity-oriented protein-protein interaction studies using LLMs, our model targets the specific functional interpretation, thereby guiding enzyme evolution. We established the VERnet model using deep mutation scanning data that underwent self-distillation, achieving an optimal accuracy of 93.5% for interpreting CYP2C9 variants. Through directed evolution at conserved positions enhanced by generative AI, we identified multiple CYP2C9 variants exhibiting a broad range of functional alterations. Additionally, a fine-tuned model optimized by AlphaFold3 significantly improved the prediction of variants involving the substitution of two amino acids. Molecular dynamics simulations revealed the structural and dynamic features of the catalytic alterations in evolved variants. The
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.